Solitary Fibrous Tumor
📧 Sign up to get email alerts when something new happens for Solitary Fibrous Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients [NA]
Trial update reporting prospective identification of predictive biomarkers for trabectedin efficacy across non-liposarcoma soft tissue sarco…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor [Phase 2]
Phase 2 trial comparing trabectedin to Adriamycin plus dacarbazine in patients with advanced solitary fibrous tumor has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Eribulin in Advanced Solitary Fibrous Tumor [Phase 2]
A Phase 2 study of eribulin in advanced solitary fibrous tumor conducted by the Italian Sarcoma Group has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma [Phase 2]
Phase 2 trial of pazopanib in solitary fibrous tumor and extraskeletal myxoid chondrosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor [Phase 2]
Phase II study evaluating axitinib in advanced solitary fibrous tumor has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.